MedTrace Logo

The Portuguese Survey on Anticoagulated Patients Register (START-Portugal-Register)

NCT03977363 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2023-05-17

No results posted yet for this study

Summary

Anticoagulants are used to prevent thrombotic events in patients with predisposing factors. However, the use of such therapies is associated with bleeding complications, which can be a serious safety issue. Thus, it is important to evaluate the safety and effectiveness of such therapies based on data collected in clinical practice in order to generate relevant scientific data that could be used to support clinical and regulatory decisions.

This is an open, prospective, multicenter, observational cohort study that aims to prospectively record the clinical history of adult patients receiving anticoagulant treatment, irrespectively of the prescribed drug and the indication for its use.

Conditions

Interventions

DRUG

Anticoagulant drugs

Anticoagulant drugs

Sponsors & Collaborators

  • CHAD

    lead OTHER

Principal Investigators

  • Francisco Batel Marques, PhD · AIBILI - Association for Innovation and Biomedical Research on Light and Image

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-27
Primary Completion
2023-03-02
Completion
2023-03-02

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03977363 on ClinicalTrials.gov